Latest News
Michelson Medical Research Foundation and Human Immunome Project Announce 2023 Michelson Prize Laureates
The Human Immunome Project (HIP) and Michelson Medical Research Foundation (MMRF) have awarded Dr. Siyuan Ding (Washington University in St. Louis), Dr. Claire Otero (Weill Cornell Medicine), and Dr. Dennis Schaefer-Babajew (Rockefeller University) the Michelson Prizes: Next Generation Grants, the organizations announced today.
2024 Michelson Philanthropies & Science Prize for Immunology Awarded for Groundbreaking Research on STING’s Role in Immune Response
Dr. Bingxu Liu has been awarded the 2024 Michelson Philanthropies & Science Prize for Immunology for his work in furthering the understanding of how the human immune system senses dangerous invading pathogens.
California Governor, Education, and Research Leaders Announce California Institute for Immunology & Immunotherapy to be Based at New UCLA Research Park
CIII’s future home in West Los Angeles was announced on January 3, 2024, by California Governor Gavin Newsom, UCLA Chancellor Gene Block, University of California President Michael Drake, and other leaders at the new UCLA Research Park, which is being built on the site of the former Westside Pavilion, two miles east of the UCLA Medical Center.
Nominations Open for the 2024 Victor Cohn Prize in Medical Science Reporting
Underwritten by Michelson Philanthropies, the $5,000 prize honors a writer for a body of work which, for reasons of accuracy, enterprise, insight, and narrative power, has made a profound contribution to public understanding of critical advances in medical science and their impact on human health.
Governor Newsom Unveils California Institute for Immunology & Immunotherapy: A Revolutionary Leap in Science and Medicine
The Institute will unite California's medical research assets to foster inter-institutional dream teams, promote health, and cultivate a thriving biotech ecosystem.
How Unique Immune Cells Can Recognize and Destroy Tumors
San Francisco— Gamma delta T cells, a special type of cell in the immune system, are incredibly effective at recognizing and killing cancer cells. Cancer patients with higher levels of these T cells in their tumors tend to fare better than those with lower levels.
Maryn McKenna's Award-Winning Reporting on Infectious Diseases and Global Health
McKenna is being honored for her reporting and writing on infectious diseases and global health and was selected from an extraordinarily competitive field of nominees.
Maryn McKenna Awarded 2023 Victor Cohn Prize
Los Angeles— Maryn McKenna (@marynmck), senior writer at WIRED and a widely published journalist and author specializing in public health, global health, and food policy, has been selected to receive the 2023 Victor Cohn Prize for Excellence in Medical Science Reporting.
Breakthrough Discoveries in Human Immunology – Michelson Philanthropies and Science/AAAS Award Transformative Research
Michelson Philanthropies and AAAS/Science announce the recipients of the 2023 Michelson Philanthropies & Science Prize for Immunology.
Pioneering a New Era of Intranasal Vaccinations: Dr. Brittany Hartwell’s Research is Recognized with 2022 Michelson Prize
Engineered to bypass mucosal barriers and improve mucosal uptake, Dr. Brittany Hartwell's intranasal vaccine promises stronger immune responses and immunity.
Oxford Researcher Romain Guyon Receives Michelson Prize for Work on Single-dose Rabies Vaccine
Romain Guyon, a Ph.D. student at the University of Oxford, is currently researching a single-dose vaccination against a disease that is widely-known, but mistakenly perceived as having little impact on human health
Artificial Intelligence Meets Immunology: Dr. Noam Auslander, 2022 Michelson Prize Recipient, Brings a New Approach to Cancer Diagnosis and Treatment
Dr. Noam Auslander’s work in artificial intelligence and immunology was born out of indecision. “I double majored in computer science and biology because I liked both and could not decide.”
Unlocking the Secrets of Immunity: Meet Dr. Jenna Guthmiller, 2022 Michelson Prize Recipient and Influenza Vaccine Innovator
Jenna Guthmiller first learned about immunology growing up on her family’s dairy farm, where her parents showed her the importance of vaccines to an animal’s health. “The idea that a dead or weakened version of a pathogen could provide protection against something that would otherwise make the animals sick was fascinating to me,” says Guthmiller.
The Next Generation of Global Health Innovators: Michelson Prize Winners Announced
The Michelson Medical Research Foundation and the Human Immunome Project award Dr. Noam Auslander, Dr. Jenna Guthmiller, Mr. Romain Guyon, and Dr. Brittany Hartwell with the Michelson Prizes: Next Generation Grants.
Philanthropy’s Role in Advancing mRNA Technology
Maintaining mRNA’s momentum will require continued investment, effective collaboration, and philanthropic contributions, Dr. Thomas Conlon of Michelson Philanthropies said on a panel at the Milken Institute’s Future of Health Summit.
Dr. Gary K. Michelson Returns to USC Michelson Center As It Celebrates Five Years
The USC Michelson Center for Convergent Bioscience is celebrating the fifth anniversary of its opening in 2017. Dr. Gary K. Michelson recently visited the center to learn about the latest research being conducted with state-of-the-art equipment.
Celebrating Science Journalism at the Science Writers 2022 Conference in Memphis
Michelson Philanthropies attended the Science Writers conference in Memphis, Tennessee, and honored two journalists for winning a prestigious medical science reporting award.
Dr. Paul Bastard Says Support Early-Career Scientists
In a recent Science podcast, Michelson Philanthropies & Science Prize for Immunology recipient Dr. Paul Bastard discussed his groundbreaking research on Covid deaths and advocated for increased funding for young scientists.
Progress in Vaccine Development for Infectious Diseases
Michelson Philanthropies celebrated this year's winners of its Michelson Prizes: Next Generation Grants and Michelson Philanthropies & Science Prize for Immunology during a Keystone Symposia conference: Progress in Vaccine Development for Infectious Diseases. Watch the full event.
Statement on Governor Newsom’s Proposed Budget Allocation to Support the Establishment of the California Institute for Immunology & Immunotherapy
Gary K. Michelson, M.D., issued a statement following the announcement of Governor Gavin Newsom’s budget proposal to invest $500 million towards the establishment of the California Institute for Immunology & Immunotherapy.
